MedTech Dive August 30, 2023
As Abbott develops a line of wearable wellness devices, and Dexcom makes a CGM for people with diabetes who don’t take insulin, both companies are turning to new users for future growth.
In a year marked by the launch of new diabetes devices, Abbott and Dexcom announced plans for new sensors intended for people who don’t take insulin.
Abbott Laboratories debuted a new wearable in July designed to help people without diabetes track glucose spikes and lows. The company, which makes continuous glucose monitors to help people manage their diabetes, quietly rolled out a new website for the consumer-facing device called Lingo, which is currently available in the U.K.
Abbott is billing the device as “Your personal metabolic...
Today's Sponsors
Today's Sponsor